Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,000,000 | 945,000 | 858,000 | 929,000 | 908,000 |
| Receivables | 178,000 | 208,000 | 186,000 | 187,000 | 180,000 |
| Inventories | 93,000 | 91,000 | 93,000 | 86,000 | 90,000 |
| Other current assets | 21,000 | 23,000 | 50,000 | 0 | 0 |
| TOTAL | $1,292,000 | $1,267,000 | $1,187,000 | $1,202,000 | $1,178,000 |
| Non-Current Assets | |||||
| PPE Net | 58,000 | 59,000 | 60,000 | 57,000 | 54,000 |
| Intangibles | 88,000 | 60,000 | 62,000 | 62,000 | 63,000 |
| Other Non-Current Assets | 233,000 | 225,000 | 222,000 | 226,000 | 256,000 |
| TOTAL | $379,000 | $344,000 | $344,000 | $345,000 | $373,000 |
| Total Assets | $1,671,000 | $1,611,000 | $1,531,000 | $1,547,000 | $1,551,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,000 | 4,000 | 4,000 | 4,000 | 4,000 |
| Accounts payable and accrued liabilities | 527,000 | 529,000 | 524,000 | 489,000 | 480,000 |
| Other current liabilities | 80,000 | 89,000 | 48,000 | 148,000 | 139,000 |
| TOTAL | $633,000 | $656,000 | $599,000 | $659,000 | $684,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 239,000 | 229,000 | 230,000 | 231,000 | 232,000 |
| Other Non-Current Liabilities | 566,000 | 562,000 | 620,000 | 577,000 | 577,000 |
| TOTAL | $805,000 | $791,000 | $850,000 | $808,000 | $809,000 |
| Total Liabilities | $1,438,000 | $1,447,000 | $1,449,000 | $1,467,000 | $1,493,000 |
| Shareholders' Equity | |||||
| Common Shares | 73,000 | 73,000 | 73,000 | 73,000 | 73,000 |
| Retained earnings | 1,460,000 | 1,392,000 | 1,311,000 | 1,324,000 | 1,310,000 |
| Other shareholders' equity | -1,306,000 | -1,307,000 | -1,308,000 | -1,323,000 | -1,331,000 |
| TOTAL | $233,000 | $164,000 | $82,000 | $80,000 | $58,000 |
| Total Liabilities And Equity | $1,671,000 | $1,611,000 | $1,531,000 | $1,547,000 | $1,551,000 |